Photodynamic Therapy

[1]  M. Korbelik,et al.  Cellular levels of photosensitisers in tumours: the role of proximity to the blood supply. , 1994, British Journal of Cancer.

[2]  Masoud Panjehpour,et al.  Photodynamic therapy trials with lutetium texaphyrin (Lu-Tex) in patients with locally recurrent breast cancer , 1998, Photonics West - Biomedical Optics.

[3]  S. Gibson,et al.  Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas. , 1990, Cancer research.

[4]  THE EFFECTS OF ASPIRIN ON MICROVASCULATURE AFTER PHOTODYNAMIC THERAPY , 1993, Photochemistry and photobiology.

[5]  Tayyaba Hasan,et al.  Rapid Control of Wound Infections by Targeted Photodynamic Therapy Monitored by In Vivo Bioluminescence Imaging ¶ , 2002, Photochemistry and photobiology.

[6]  Anuradha Godavarty,et al.  Near- Infrared Fluorescence Imaging and Spectroscopy in Random Media and Tissues , 2003 .

[7]  L. O. Svaasand,et al.  Photodynamic and photohyperthermic response of malignant tumors. , 1985, Medical physics.

[8]  T. Dougherty,et al.  Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. , 1981, Cancer research.

[9]  E. Manseau,et al.  Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression. , 1979, Journal of the National Cancer Institute.

[10]  L. Pimenta,et al.  Photosensitization of in vitro biofilms by toluidine blue O combined with a light-emitting diode. , 2006, European journal of oral sciences.

[11]  M. Korbelik,et al.  Low density lipoprotein receptor pathway in the delivery of Photofrin: how much is it relevant for selective accumulation of the photosensitizer in tumors? , 1992, Journal of photochemistry and photobiology. B, Biology.

[12]  J Moan,et al.  5‐Aminolevulinic acid‐based photodynamic therapy , 1997, Cancer.

[13]  F. Hetzel,et al.  Sequencing of combined hyperthermia and photodynamic therapy. , 1996, Radiation research.

[14]  C. Gomer,et al.  Decreased expression and function of alpha-2 macroglobulin receptor/low density lipoprotein receptor-related protein in photodynamic therapy-resistant mouse tumor cells. , 1995, Cancer research.

[15]  M. Korbelik,et al.  Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. , 1995, British Journal of Cancer.

[16]  H. S. de Bruijn,et al.  Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. , 1996, Cancer research.

[17]  D. Corry,et al.  Antimicrobial photodynamic therapy: assessment of genotoxic effects on keratinocytes in vitro , 2003, The British journal of dermatology.

[18]  P. Low,et al.  Tumor detection using folate receptor-targeted imaging agents , 2008, Cancer and Metastasis Reviews.

[19]  K. Berg,et al.  Site-Specific Drug Delivery by Photochemical Internalization Enhances the Antitumor Effect of Bleomycin , 2005, Clinical Cancer Research.

[20]  W. Star,et al.  Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. , 1986, Cancer research.

[21]  N. Oleinick,et al.  Rapid Tyrosine Phosphorylation of HS1 in the Response of Mouse Lymphoma L5178Y‐R Cells to Photodynamic Treatment Sensitized by the Phthalocyanine Pc 4 , 1997, Photochemistry and photobiology.

[22]  Klara Stefflova,et al.  Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers. , 2009, Journal of medicinal chemistry.

[23]  J. Norton,et al.  Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. , 1990, Journal of the National Cancer Institute.

[24]  Paola Taroni,et al.  Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light , 1994, Anti-cancer drugs.

[25]  N. Yamamoto,et al.  TUMORICIDAL CAPACITIES OF MACROPHAGES PHOTODYNAMICALLY ACTIVATED WITH HEMATOPORPHYRIN DERIVATIVE , 1992, Photochemistry and photobiology.

[26]  S. Steinberg,et al.  Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. , 1993, International journal of radiation oncology, biology, physics.

[27]  B. Henderson,et al.  SITES OF PHOTODAMAGE in vivo and in vitro BY A CATIONIC PORPHYRIN , 1995, Photochemistry and photobiology.

[28]  C J Gomer,et al.  NUCLEAR FACTOR κB BINDING ACTIVITY IN MOUSE L1210 CELLS FOLLOWING PHOTOFRIN II‐MEDIATED PHOTOSENSITIZATION , 1993, Photochemistry and photobiology.

[29]  M. G. Dilkes,et al.  A comparison of novel light sources for photodynamic therapy , 1997, Lasers in Medical Science.

[30]  E. El-Omar,et al.  Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[31]  C. Gomer,et al.  Increased Photosensitivity in HL60 Cells Expressing Wild‐Type p53 , 1997, Photochemistry and photobiology.

[32]  B W Henderson,et al.  OXYGEN LIMITATION OF DIRECT TUMOR CELL KILL DURING PHOTODYNAMIC TREATMENT OF A MURINE TUMOR MODEL , 1989, Photochemistry and photobiology.

[33]  M G Nichols,et al.  Oxygen diffusion and reaction kinetics in the photodynamic therapy of multicell tumour spheroids. , 1994, Physics in medicine and biology.

[34]  Q. Peng,et al.  PHOTOSENSITIZING EFFICIENCIES, TUMOR‐ and CELLULAR UPTAKE OF DIFFERENT PHOTOSENSITIZING DRUGS RELEVANT FOR PHOTODYNAMIC THERAPY OF CANCER , 1987, Photochemistry and photobiology.

[35]  W R Greco,et al.  An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. , 1997, Cancer research.

[36]  M W Berns,et al.  Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. , 1988, Journal of the National Cancer Institute.

[37]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[38]  C Scully,et al.  Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. , 1995, The Journal of antimicrobial chemotherapy.

[39]  Q. Peng,et al.  5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.

[40]  M. Robson.  Wound Infection: A Failure of Wound Healing Caused by an Imbalance of Bacteria , 1997 .

[41]  H Stepp,et al.  Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. , 1996, The Journal of urology.

[42]  W. Star,et al.  PILOT STUDY ON LIGHT DOSIMETRY FOR ENDOBRONCHIAL PHOTODYNAMIC THERAPY , 1993, Photochemistry and photobiology.

[43]  A. Girotti,et al.  GLUCOSE ADMINISTRATION AUGMENTS IN VIVO UPTAKE AND PHOTOTOXICITY OF THE TUMOR‐LOCALIZING FRACTION OF HEMATOPORPHYRIN DERIVATIVE , 1989, Photochemistry and photobiology.

[44]  G. Jori,et al.  PHOTOSENSITIZATION OF MITOCHONDRIA BY LIPOSOME‐BOUND PORPHYRINS , 1993, Photochemistry and photobiology.

[45]  B. C. Webb,et al.  Candida-associated denture stomatitis. Aetiology and management: a review. Part 3. Treatment of oral candidosis. , 1998, Australian dental journal.

[46]  B W Henderson,et al.  Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. , 1987, Cancer research.

[47]  Satomi Takahashi,et al.  Relationship of lymph node metastasis to primary tumor size and microscopic appearance of roentgenographically occult lung cancer. , 1989, The American journal of surgical pathology.

[48]  J. Kennedy,et al.  Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. , 1996, Journal of clinical laser medicine & surgery.

[49]  T. Dubbelman,et al.  Synergistic Interaction of Photodynamic Treatment with the Sensitizer Aluminum Phthalocyanine and Hyperthermia on Loss of Clonogenicity of CHO Cells , 1996, Photochemistry and photobiology.

[50]  J. Kennedy,et al.  The possible role of ionic species in selective biodistribution of photochemotherapeutic agents toward neoplastic tissue. , 1990, Journal of photochemistry and photobiology. B, Biology.

[51]  J. Levy,et al.  Photofrin, but not benzoporphyrin derivative, stimulates hematopoiesis in the mouse. , 1993, Immunopharmacology.

[52]  Q. Peng,et al.  Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. , 1996, Ultrastructural pathology.

[53]  Philip S Low,et al.  Folate receptor-mediated drug targeting: from therapeutics to diagnostics. , 2005, Journal of pharmaceutical sciences.

[54]  D. Kessel,et al.  Mitochondrial photodamage and PDT-induced apoptosis. , 1998, Journal of photochemistry and photobiology. B, Biology.

[55]  T. Cotter,et al.  Apoptosis-the story so far... , 1996, Experientia.

[56]  Philip S Low,et al.  Folate-mediated delivery of macromolecular anticancer therapeutic agents. , 2002, Advanced drug delivery reviews.

[57]  D. Cortese,et al.  Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. , 1992, Chest.

[58]  M. Biel.  Photodynamic therapy and the treatment of head and neck cancers. , 1996, Journal of clinical laser medicine & surgery.

[59]  T. Dougherty,et al.  Correlation between Site ll‐Specific Human Serum Albumin (HSA) Binding Affinity and Murine in vivo Photosensitizing Efficacy of Some Photofrin Components , 1997, Photochemistry and photobiology.

[60]  M. Eden,et al.  The pH of rat tumors measured in vivo. , 1955, Journal of the National Cancer Institute.

[61]  J. Becker,et al.  Anti-cancer therapies targeting the tumor stroma , 2007, Cancer Immunology, Immunotherapy.

[62]  Z. Malik,et al.  The antibacterial activity of haemin compared with cobalt, zinc and magnesium protoporphyrin and its effect on potassium loss and ultrastructure of Staphylococcus aureus. , 1993, FEMS microbiology letters.

[63]  F. Hetzel,et al.  Tumor Oxygenation Changes Post‐Photodynamic Therapy , 1996, Photochemistry and photobiology.

[64]  T. Flanigan,et al.  Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  H. Pass,et al.  Use of photodynamic therapy for the management of pleural malignancies. , 1995, Seminars in surgical oncology.

[66]  J. Moan,et al.  The mechanism of photodynamic inactivation of human cells in vitro in the presence of haematoporphyrin. , 1979, British Journal of Cancer.

[67]  R. Nerlinger,et al.  pH distribution in human tumors. , 1985, International journal of radiation oncology, biology, physics.

[68]  H. Dvorak,et al.  Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. , 1979, Journal of immunology.

[69]  L. Gerweck,et al.  Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. , 1996, Cancer research.

[70]  J. Krosl,et al.  Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. , 1996, Cancer research.

[71]  I. Otero,et al.  Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[72]  M. Endres,et al.  In Vivo Imaging of the Inflammatory Receptor CD40 After Cerebral Ischemia Using a Fluorescent Antibody , 2008, Stroke.

[73]  H. Kato,et al.  Photodynamic therapy for early stage bronchogenic carcinoma. , 1996, Journal of clinical laser medicine & surgery.

[74]  Hedy E. Larkin,et al.  Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells. , 1993, Cancer research.

[75]  U Althaus,et al.  Effect of drug‐light interval on photodynamic therapy with meta‐tetrahydroxyphenylchlorin in malignant mesothelioma , 1993, International journal of cancer.

[76]  R. Ouellet,et al.  THE EFFECTS OF PHOTODYNAMIC THERAPY USING DIFFERENTLY SUBSTITUTED ZINC PHTHALOCYANINES ON VESSEL CONSTRICTION, VESSEL LEAKAGE AND TUMOR RESPONSE , 1993, Photochemistry and photobiology.

[77]  David Kessel,et al.  Mechanisms of phototoxicity catalyzed by two porphycenes , 1995, Photonics West.

[78]  C. Gomer,et al.  Differential photosensitivity in wild-type and mutant p53 human colon carcinoma cell lines. , 1998, Journal of photochemistry and photobiology. B, Biology.

[79]  P. Mróz,et al.  Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[80]  M. E. Kenney,et al.  Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines. , 1995, British Journal of Cancer.

[81]  C. Gomer,et al.  Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. , 2002, Cancer research.

[82]  T. Wieman,et al.  Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction. , 1990, Cancer research.

[83]  A. Richter,et al.  THE PLASMA DISTRIBUTION OF BENZOPORPHYRIN DERIVATIVE and THE EFFECTS OF PLASMA LIPOPROTEINS ON ITS BIODISTRIBUTION , 1990, Photochemistry and photobiology.

[84]  M L Agarwal,et al.  Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. , 1991, Cancer research.

[85]  J. Levy,et al.  Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. , 1983, Journal of immunology.

[86]  Tayyaba Hasan,et al.  Importance of fluence rate in photodynamic therapy with ALA-induced PpIX and BPD-MA in a rat bladder tumor model , 1995, Photonics West.

[87]  J. Levy,et al.  Photodynamic Treatment with Benzoporphyrin Derivative Monoacid Ring A Produces Protein Tyrosine Phosphorylation Events and DNA Fragmentation in Murine P815 Cells , 1998, Photochemistry and photobiology.

[88]  M. Korbelik,et al.  Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. , 1997, British Journal of Cancer.

[89]  G. Jori,et al.  Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. , 1996, Journal of photochemistry and photobiology. B, Biology.

[90]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[91]  Johan Emelian Moan,et al.  Photodynamic membrane damage of hematoporphyrin derivative-treated NHIK 3025 cells in vitro , 1981 .

[92]  B. Henderson,et al.  Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. , 1998, British Journal of Cancer.

[93]  S. Orrenius,et al.  Signalling mechanisms and oxidative stress in apoptosis. , 1995, Toxicology letters.

[94]  G Morstyn,et al.  Uptake of hematoporphyrin derivative by normal and malignant cells: effect of serum, pH, temperature, and cell size. , 1985, Cancer research.

[95]  B. Wilson,et al.  Photodynamic therapy for recurrent supratentorial gliomas. , 1995, Seminars in surgical oncology.

[96]  Daniel R. Doiron,et al.  SnET2: clinical update , 1996, Photonics West.

[97]  S. Gibson,et al.  Photosensitizing effects of Photofrin II on the site-selected mitochondrial enzymes adenylate kinase and monoamine oxidase. , 1987, Cancer research.

[98]  J. Boutin.  Tyrosine protein kinase inhibition and cancer. , 1994, The International journal of biochemistry.

[99]  G. V. van Dongen,et al.  The promise of immuno-PET in radioimmunotherapy. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[100]  J. Moan,et al.  Changes in antigen expression on human FME melanoma cells after exposure to photoactivated hematoporphyrin derivative. , 1986, Cancer research.

[101]  X. Hou,et al.  Characterization of a tunable optical parametric oscillator laser system for multielement flame laser excited atomic fluorescence spectrometry of cobalt, copper, lead, manganese, and thallium in buffalo river sediment. , 1997, Analytical chemistry.

[102]  M. Rinaldi,et al.  Antifungal susceptibility testing. , 2006, Infectious disease clinics of North America.

[103]  W. Powderly,et al.  Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. , 1993, The Journal of infectious diseases.

[104]  C J Gomer,et al.  Photodynamic therapy mediated induction of early response genes. , 1994, Cancer research.

[105]  A. Goetz,et al.  Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding. , 1995, Cancer research.

[106]  M. Korbelik,et al.  Induction of tumor immunity by photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.

[107]  A. Leunig,et al.  Evaluation of photodynamic therapy-induced heating of hamster melanoma and its effect on local tumour eradication. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[108]  Johan Emelian Moan,et al.  Choice of the proper wavelength for photochemotherapy , 1996, European Conference on Biomedical Optics.

[109]  Mladen Korbelik,et al.  ENHANCED MACROPHAGE CYTOTOXICITY AGAINST TUMOR CELLS TREATED WITH PHOTODYNAMIC THERAPY , 1994, Photochemistry and photobiology.

[110]  S. Chanock,et al.  Transmission of an Azole-Resistant Isogenic Strain of Candida albicans among Human Immunodeficiency Virus-Infected Family Members with Oropharyngeal Candidiasis , 1999, Journal of Clinical Microbiology.

[111]  J. Moan,et al.  Photodynamic effects on human cells exposed to light in the presence of hematoporphyrin. pH effects. , 1980, Cancer letters.

[112]  J. Alexander,et al.  Relationship between extent of burn injury and magnitude of microbial translocation from the intestine. , 1993, The Journal of burn care & rehabilitation.

[113]  A. White,et al.  Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[114]  Avigdor Scherz,et al.  Light‐dependent Oxygen Consumption in Bacteriochlorophyll‐Serine‐treated Melanoma Tumors: On‐line Determination Using a Tissue‐inserted Oxygen Microsensor , 1997, Photochemistry and photobiology.

[115]  B. Overholt,et al.  Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. , 1995, Gastrointestinal endoscopy.

[116]  E. Hovig,et al.  Evaluation of various polyethylenimine formulations for light-controlled gene silencing using small interfering RNA molecules. , 2008, Oligonucleotides.

[117]  J. Kennedy,et al.  The effect of tissue and cellular pH on the selective biodistribution of porphyrin-type photochemotherapeutic agents: a volumetric titration study. , 1990, Journal of photochemistry and photobiology. B, Biology.

[118]  I. Tannock,et al.  Acid pH in tumors and its potential for therapeutic exploitation. , 1989, Cancer research.

[119]  D. Vaux,et al.  The molecular biology of apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[120]  M. Ratnam,et al.  The folate receptor: What does it promise in tissue-targeted therapeutics? , 2007, Cancer and Metastasis Reviews.

[121]  R. Straight,et al.  SYSTEMIC IMMUNOSUPPRESSION INDUCED BY PHOTODYNAMIC THERAPY (PDT) IS ADOPTIVELY TRANSFERRED BY MACROPHAGES , 1989, Photochemistry and photobiology.

[122]  M. Ochsner.  Photophysical and photobiological processes in the photodynamic therapy of tumours. , 1997, Journal of photochemistry and photobiology. B, Biology.

[123]  B. Henderson,et al.  PHOTOSENSITIZATION OF MURINE TUMOR, VASCULATURE and SKIN BY 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRIN , 1995, Photochemistry and photobiology.

[124]  M G Nichols,et al.  The Mechanism of Photofrin Photobleaching and Its Consequences for Photodynamic Dosimetry , 1997, Photochemistry and photobiology.

[125]  G. Kroemer,et al.  Bcl-2 inhibits the mitochondrial release of an apoptogenic protease , 1996, The Journal of experimental medicine.

[126]  J. Behr,et al.  Systemic linear polyethylenimine (L‐PEI)‐mediated gene delivery in the mouse , 2000, The journal of gene medicine.

[127]  K. Berg,et al.  THE PHOTODEGRADATION OF PORPHYRINS IN CELLS CAN BE USED TO ESTIMATE THE LIFETIME OF SINGLET OXYGEN , 1991, Photochemistry and photobiology.

[128]  N. Oleinick,et al.  APOPTOSIS DURING PHOTODYNAMIC THERAPY‐INDUCED ABLATION OF RIF‐1 TUMORS IN C3H MICE: ELECTRON MICROSCOPIC, HISTOPATHOLOGIC AND BIOCHEMICAL EVIDENCE , 1993, Photochemistry and photobiology.

[129]  M. Robson,et al.  Bacterial quantification of open wounds. , 1969, Military medicine.

[130]  B. Henderson,et al.  LIPID‐ASSOCIATED METHYLPHEOPHORBIDE‐A (HEXYL‐ETHER) AS A PHOTODYNAMIC AGENT IN TUMOR‐BEARING MICE , 1993, Photochemistry and photobiology.

[131]  C. Piantadosi,et al.  Release of cytochrome c from liver mitochondria during permeability transition. , 1997, Biochemical and biophysical research communications.

[132]  A. Girotti,et al.  Role of lipid peroxidation in hematoporphyrin derivative-sensitized photokilling of tumor cells: protective effects of glutathione peroxidase. , 1989, Cancer research.

[133]  J. Peter,et al.  Emergence of Resistance of Candida albicans to Clotrimazole in Human Immunodeficiency Virus-Infected Children: In Vitro and Clinical Correlations , 2000, Journal of Clinical Microbiology.

[134]  N M Green,et al.  Avidin and streptavidin. , 1990, Methods in enzymology.

[135]  Philip S Low,et al.  Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. , 2008, Accounts of chemical research.

[136]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[137]  E. Reddi,et al.  The role of lipoproteins in the delivery of tumour-targeting photosensitizers. , 1993, The International journal of biochemistry.

[138]  G. Kroemer,et al.  Mitochondrial permeability transition triggers lymphocyte apoptosis. , 1996, Journal of immunology.

[139]  L. Polo,et al.  The effect of different liposomal formulations on the interaction of Zn(II)-phthalocyanine with isolated low and high density lipoproteins. , 1995, The international journal of biochemistry & cell biology.

[140]  H. Oppelaar,et al.  Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC. , 1996, Radiation research.

[141]  S. Koletar,et al.  Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus , 1990, Antimicrobial Agents and Chemotherapy.

[142]  J. Levy,et al.  STRESS PROTEIN EXPRESSION IN MURINE TUMOR CELLS FOLLOWING PHOTODYNAMIC THERAPY WITH BENZOPORPHYRIN DERIVATIVE , 1993, Photochemistry and photobiology.

[143]  N. Joshi,et al.  Ca2+ INFLUX INDUCED BY PHOTODYNAMIC ACTION IN HUMAN CEREBRAL GLIOMA (U‐87 MG) CELLS: POSSIBLE INVOLVEMENT OF A CALCIUM CHANNEL , 1994, Photochemistry and photobiology.

[144]  Barbara W. Henderson,et al.  Effects of fluence rate on cytoxicity during photodynamic therapy , 1997, Photonics West - Biomedical Optics.

[145]  H. Goossens,et al.  COMPARISON OF FLUCONAZOLE AND KETOCONAZOLE FOR OROPHARYNGEAL CANDIDIASIS IN AIDS , 1989, The Lancet.

[146]  Jin He,et al.  Signal transduction and metabolic changes during tumor cell apoptosis following phthalocyanine-sensitized photodynamic therapy , 1993, Photonics West - Lasers and Applications in Science and Engineering.

[147]  C. Gomer.  PRECLINICAL EXAMINATION OF FIRST and SECOND GENERATION PHOTOSENSITIZERS USED IN PHOTODYNAMIC THERAPY , 1991, Photochemistry and photobiology.

[148]  J. Moan,et al.  Cellular uptake and photodynamic effect of hematoporphyrin , 1981 .

[149]  D. Stevens,et al.  Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily. , 1991, Archives of internal medicine.

[150]  B. Henderson,et al.  DRUG and LIGHT DOSE DEPENDENCE OF PHOTODYNAMIC THERAPY: A STUDY OF TUMOR and NORMAL TISSUE RESPONSE , 1987, Photochemistry and photobiology.

[151]  W. Strull,et al.  Fluconazole-resistant Candida in AIDS patients. Report of two cases. , 1993, Oral surgery, oral medicine, and oral pathology.

[152]  T. Mang,et al.  Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. , 1985, Cancer research.

[153]  J. Moan,et al.  Release of lysosomal enzymes and lactate dehydrogenase due to hematoporphyrin derivative and light irradiation of NHIK 3025 cells in vitro. , 1982, Annals of clinical research.

[154]  Seamus J. Martin,et al.  Cytochrome c activation of CPP32‐like proteolysis plays a critical role in a Xenopus cell‐free apoptosis system , 1997, The EMBO journal.

[155]  J. Krosl,et al.  The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. , 1996, Cancer research.

[156]  J. Levy.  Photosensitizers in photodynamic therapy. , 1994, Seminars in Oncology.

[157]  D. Kessel,et al.  Side effects and photosensitization of human tissues after aminolevulinic acid. , 1997, The Journal of surgical research.

[158]  C. M. Martin,et al.  RELATIONSHIP OF QUANTITATIVE WOUND BACTERIAL COUNTS TO HEALING OF DECUBITI: EFFECT OF TOPICAL GENTAMICIN. , 1964, Antimicrobial agents and chemotherapy.

[159]  Rakesh K. Jain,et al.  Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.

[160]  V. Fingar,et al.  Vascular effects of photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.

[161]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[162]  K. Berg,et al.  Photochemically Enhanced Gene Delivery of EGF Receptor-targeted DNA Polyplexes , 2004, Journal of drug targeting.

[163]  A. Richter,et al.  THE EFFECTS OF PLASMA LIPOPROTEINS ON in vitro TUMOR CELL KILLING and in vivo TUMOR PHOTOSENSITIZATION WITH BENZOPORPHYRIN DERIVATIVE , 1991, Photochemistry and photobiology.

[164]  Faten Gad,et al.  Effects of Growth Phase and Extracellular Slime on Photodynamic Inactivation of Gram-Positive Pathogenic Bacteria , 2004, Antimicrobial Agents and Chemotherapy.

[165]  H. Bergh,et al.  In Vivo Fluence Rate Effect in Photodynamic Therapy of Early Cancers with Tetra(m‐hydroxyphenyl)chlorin , 1996, Photochemistry and photobiology.

[166]  P Franco,et al.  Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210). , 1984, Cancer research.

[167]  Barbara W. Henderson,et al.  Bacteriochlorophyll-a as photosensitizer for photodynamic treatment of transplantable murine tumors , 1990, Photonics West - Lasers and Applications in Science and Engineering.

[168]  M F Stranc,et al.  Assessment of tissue viability using near-infrared spectroscopy. , 1998, British journal of plastic surgery.

[169]  M. Castillo,et al.  Indications for Adult and Pediatric Magnetic Resonance Imaging Gadolinium-Enhanced Cisternography and Myelography: Experience and Review of the Literature , 2008 .

[170]  Qing Ge,et al.  Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[171]  T J Dougherty,et al.  Intracavitary photodynamic therapy for malignant pleural mesothelioma. , 1995, Seminars in surgical oncology.

[172]  D. Denning,et al.  Fluconazole‐resistant candidosis in an HIV cohort , 1994, AIDS.

[173]  M. Winter,et al.  Fluconazole for oropharyngeal candidiasis in anti‐HIV positive haemophiliacs , 1991, Alimentary pharmacology & therapeutics.

[174]  C. Kauffman,et al.  Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. , 1994, The American journal of medicine.

[175]  T. Veikkola,et al.  Vascular Endothelial Growth Factor-C Stimulates the Migration and Proliferation of Kaposi’s Sarcoma Cells* , 1999, The Journal of Biological Chemistry.

[176]  B W Henderson,et al.  Role of cytokines in photodynamic therapy-induced local and systemic inflammation , 2003, British Journal of Cancer.

[177]  C. Whitehurst,et al.  Development of an alternative light source to lasers for photodynamic therapy: 1. Comparative in vitro dose response characteristics , 2006, Lasers in Medical Science.

[178]  T. Okunaka,et al.  A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[179]  D. Kessel,et al.  The Role of Subcellular Localization in Initiation of Apoptosis by Photodynamic Therapy , 1997, Photochemistry and photobiology.

[180]  R. Chaisson,et al.  Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients. , 1996, The Journal of infectious diseases.

[181]  Touqir Zahra,et al.  Targeted photodynamic therapy of established soft-tissue infections in mice , 2004, SPIE BiOS.

[182]  Guy Makin,et al.  Apoptosis and cancer chemotherapy , 2000, Cell and Tissue Research.

[183]  M. Korbelik,et al.  Distribution of Photofrin between tumour cells and tumour associated macrophages. , 1991, British Journal of Cancer.

[184]  C. Gomer,et al.  INCREASED TRANSCRIPTION AND TRANSLATION OF HEME OXYGENASE IN CHINESE HAMSTER FIBROBLASTS FOLLOWING PHOTODYNAMIC STRESS OR PHOTOFRIN II INCUBATION , 1991, Photochemistry and photobiology.

[185]  S. Flock,et al.  Effect of aspirin on photodynamic therapy utilizing chloroaluminum sulfonated phthalocyanine (CASP) , 1992, Lasers in surgery and medicine.

[186]  M. Agarwal,et al.  ELEVATION OF GRP‐78 AND LOSS OF HSP‐70 FOLLOWING PHOTODYNAMIC TREATMENT OF V79 CELLS: SENSITIZATION BY NIGERICIN , 1995, Photochemistry and photobiology.

[187]  F. Baquero,et al.  Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[188]  Sharon Thomsen,et al.  PHOTODYNAMIC THERAPY WITH PHOTOFRIN II INDUCES PROGRAMMED CELL DEATH IN CARCINOMA CELL LINES , 1994, Photochemistry and photobiology.

[189]  V. Ntziachristos.  Fluorescence molecular imaging. , 2006, Annual review of biomedical engineering.

[190]  C. Salet.  Hematoporphyrin and hematoporphyrin-derivative photosensitization of mitochondria. , 1986, Biochimie.

[191]  B. Henderson,et al.  Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. , 1997, Cancer research.

[192]  S. Gibson,et al.  Photosensitizing effects of hematoporphyrin derivative and photofrin II on the plasma membrane enzymes 5'-nucleotidase, Na+K+-ATPase, and Mg2+-ATPase in R3230AC mammary adenocarcinomas. , 1988, Cancer research.

[193]  H. Pass,et al.  Intrathoracic photodynamic therapy: A canine normal tissue tolerance study and early clinical experience , 1994, Lasers in surgery and medicine.

[194]  R. Schiffelers,et al.  Delivery of siRNA to the target cell cytoplasm: photochemical internalization facilitates endosomal escape and improves silencing efficiency, in vitro and in vivo. , 2008, Current pharmaceutical design.

[195]  E. Reddi,et al.  Quick fixes for quicksilver. , 1998, Environmental health perspectives.

[196]  L. de Repentigny,et al.  Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group. , 1996, Chemotherapy.

[197]  K. Berg,et al.  Photochemical disruption of endocytic vesicles before delivery of drugs: a new strategy for cancer therapy , 2002, British Journal of Cancer.

[198]  P. Speight,et al.  Photodynamic therapy using 5‐aminolevulinic acid for premalignant and malignant lesions of the oral cavity , 1996, Cancer.

[199]  C J Gomer,et al.  Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins. , 1996, Cancer research.

[200]  G. Kroemer,et al.  Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis , 1996, FEBS letters.

[201]  Q. Peng,et al.  The effect of glucose administration on the uptake of photofrin II in a human tumor xenograft. , 1991, Cancer letters.

[202]  C. Gomer,et al.  Photosensitization with derivatives of chlorin p6. , 1995, Journal of Photochemistry and Photobiology. B: Biology.

[203]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[204]  D. Kessel,et al.  Rapid Initiation of Apoptosis by Photodynamic Therapy , 1996, Photochemistry and photobiology.

[205]  J Moan,et al.  Lysosomes and Microtubules as Targets for Photochemotherapy of Cancer , 1997, Photochemistry and photobiology.

[206]  E. Krenning,et al.  Pemetrexed Improves Tumor Selectivity of 111In-DTPA-Folate in Mice with Folate Receptor–Positive Ovarian Cancer , 2008, Journal of Nuclear Medicine.

[207]  Darren L. Johnson.  Photodynamic Therapy for Barrett's Esophagus , 2000 .

[208]  Ursula Nestle,et al.  Biological imaging in radiation therapy: role of positron emission tomography , 2009, Physics in medicine and biology.

[209]  M. Rodgers,et al.  DEPOLARIZATION OF MOUSE MYELOMA CELL MEMBRANES DURING PHOTODYNAMIC ACTION , 1990, Photochemistry and photobiology.

[210]  D. Kessel,et al.  An apoptotic response to photodynamic therapy with endogenous protoporphyrin in vivo. , 1996, Journal of photochemistry and photobiology. B, Biology.

[211]  N. Nishikawa,et al.  Cyclooxygenase‐2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity , 2004, The British journal of dermatology.

[212]  T. Foster,et al.  Oxygen consumption and diffusion effects in photodynamic therapy. , 1991, Radiation research.

[213]  Y. Carmeli,et al.  The Establishment of a Pseudomonas aeruginosa-Infected Burn-Wound Sepsis Model and the Effect of Imipenem Treatment , 2006, Annals of plastic surgery.

[214]  T. Wieman,et al.  THE EFFECTS OF THROMBOXANE INHIBITORS ON THE MICROVASCULAR AND TUMOR RESPONSE TO PHOTODYNAMIC THERAPY , 1993, Photochemistry and photobiology.

[215]  C. Gomer,et al.  Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization. , 1991, Cancer research.

[216]  T. Krizek,et al.  Bacterial growth and skin graft survival , 1967 .

[217]  A. Cincotta,et al.  Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas. , 1994, Cancer research.

[218]  M. Stein,et al.  Hierarchical pattern of mucosal candida infections in HIV-seropositive women. , 1990, The American journal of medicine.

[219]  I. Freitas.  Lipid accumulation: the common feature to photosensitizer-retaining normal and malignant tissues. , 1990, Journal of photochemistry and photobiology. B, Biology.

[220]  N. Brasseur,et al.  Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow. , 1996, Anticancer research.

[221]  P. H. Moore,et al.  Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response. , 1994, Cancer research.

[222]  M. Obochi,et al.  Prolonged skin allograft survival after photodynamic therapy associated with modification of donor skin antigenicity. , 1997, Transplantation.

[223]  C. glaeser,et al.  [Oropharyngeal candidiasis]. , 2009, Praxis.

[224]  R Baumgartner,et al.  Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. , 1994, Urology.

[225]  S. Calderwood,et al.  Effects of hyperglycemia and hyperthermia on the pH, glycolysis, and respiration of the Yoshida sarcoma in vivo. , 1979, Journal of the National Cancer Institute.

[226]  S. Bown,et al.  Photodynamic therapy in gastroenterology. , 1997, Gut.

[227]  D. Kessel,et al.  The phosphatase inhibitor calyculin antagonizes the rapid initiation of apoptosis by photodynamic therapy. , 1996, Biochemical and biophysical research communications.

[228]  S. Pelech,et al.  Stimulation of Stress-activated Protein Kinase and p38 HOG1 Kinase in Murine Keratinocytes following Photodynamic Therapy with Benzoporphyrin Derivative* , 1996, The Journal of Biological Chemistry.

[229]  H. Tideman.  Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity , 1999 .

[230]  T. Wieman,et al.  The Effects of Thrombocytopenia on Vessel Stasis and Macromolecular Leakage after Photodynamic Therapy Using Photofrin , 1997, Photochemistry and photobiology.

[231]  E. Bouza,et al.  Fluconazole-related hepatotoxicity in patients with acquired immunodeficiency syndrome. , 1991, Archives of internal medicine.

[232]  J. Ninane,et al.  A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies , 1994, European Journal of Clinical Microbiology and Infectious Diseases.

[233]  C. Gomer,et al.  Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. , 2005, Cancer research.

[234]  D. Metzger,et al.  ENHANCED SKIN ALLOGRAFT SURVIVAL AFTER PHOTODYNAMIC THERAPY: ASSOCIATION WITH LYMPHOCYTE INACTIVATION AND MACROPHAGE STIMULATION1 , 1993, Transplantation.

[235]  B. Wilson,et al.  Mitochondrial alterations in photodynamic therapy-resistant cells. , 1993, Cancer research.

[236]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[237]  A H Kaye,et al.  Photodynamic therapy of brain tumors. , 1995, Journal of clinical laser medicine & surgery.

[238]  C. Gomer,et al.  Cellular targets and molecular responses associated with photodynamic therapy. , 1996, Journal of clinical laser medicine & surgery.

[239]  J. Moan,et al.  PHOTODYNAMIC INACTIVATION OF YEAST CELLS SENSITIZED BY HEMATOPORPHYRIN , 1980, Photochemistry and photobiology.

[240]  H. Bergh,et al.  Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers , 1996, Lasers in Medical Science.

[241]  M. Robson,et al.  Biology of surgical infection. , 1973, The Surgical clinics of North America.

[242]  C. Harris,et al.  Inflammation and cancer: An ancient link with novel potentials , 2007, International journal of cancer.

[243]  M T Tseng,et al.  A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation. , 1989, Radiation research.

[244]  I. Driver,et al.  Tumor vascular shutdown following photodynamic therapy based on polyhematoporphyrin or 5-aminolevulinic Acid. , 1994, International journal of oncology.

[245]  J. Carmichael,et al.  Fluconazole-resistant Candida albicans after long-term suppressive therapy. , 1993, Archives of internal medicine.

[246]  Z. Malik,et al.  Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. , 1987, British Journal of Cancer.

[247]  D A Musser,et al.  The binding of tumor localizing porphyrins to a fibrin matrix and their effects following photoirradiation. , 1980, Research communications in chemical pathology and pharmacology.

[248]  H. Barr,et al.  Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX , 1996, The Lancet.

[249]  Britton Chance,et al.  Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters. , 2003, Bioconjugate chemistry.

[250]  P. D. Smith,et al.  Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel of hypervirulent strain. , 1990, The Journal of infectious diseases.

[251]  J Moan,et al.  PHOTODYNAMIC EFFECTS ON CELLS IN VITRO EXPOSED TO HEMATOPORPHYRIN DERIVATIVE and LIGHT , 1983, Photochemistry and photobiology.

[252]  G. Kenyon,et al.  m-THPC photodynamic therapy for head and neck cancer , 1996, Lasers in Medical Science.

[253]  W. Sluiter,et al.  Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. , 1997, Cancer research.

[254]  B. Gjertsen,et al.  Protein phosphorylation in apoptosis. , 1995, Biochimica et biophysica acta.

[255]  P. Levendag,et al.  Interaction of interstitial photodynamic therapy and interstitial hyperthermia in a rat rhabdomyosarcoma--a pilot study. , 1988, International journal of radiation oncology, biology, physics.

[256]  Cheng Y. Lin,et al.  INTERFERON-&ggr; PRODUCTION IS SUPPRESSED IN THERMALLY INJURED MICE: DECREASED PRODUCTION OF REGULATORY CYTOKINES AND CORRESPONDING RECEPTORS , 2002, Shock.

[257]  M. Agarwal,et al.  The Induction of Partial Resistance to Photodynamic Therapy by the Protooncogene BCL‐2 , 1996, Photochemistry and photobiology.

[258]  S. Hilsenbeck,et al.  A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance. , 1998, The American journal of medicine.

[259]  P. Siersema.  Photodynamic therapy for Barrett's esophagus: not yet ready for the premier league of endoscopic interventions. , 2005, Gastrointestinal endoscopy.

[260]  C. Gomer,et al.  Photodynamic therapy: Combined modality approaches targeting the tumor microenvironment , 2006, Lasers in surgery and medicine.

[261]  O. Danos,et al.  Synthesis of linear polyethylenimine derivatives for DNA transfection. , 2003, Bioconjugate chemistry.

[262]  U. Nseyo,et al.  Urinary cytokines following photodynamic therapy for bladder cancer. A preliminary report. , 1990, Urology.

[263]  J. Moan.  PORPHYRIN PHOTOSENSITIZATION AND PHOTOTHERAPY , 1986, Photochemistry and photobiology.

[264]  F. Guillemin,et al.  Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy. , 2005, Bioorganic & medicinal chemistry.

[265]  C. Gomer,et al.  Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model. , 2006, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[266]  K. Berg,et al.  Photochemical internalization: a new tool for drug delivery. , 2007, Current pharmaceutical biotechnology.

[267]  W. Star,et al.  Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas. , 1993, Cancer research.

[268]  M. Pfaller,et al.  Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[269]  M. Korbelik,et al.  Photofrin uptake by murine macrophages. , 1991, Cancer research.

[270]  P. Gullino,et al.  Modifications of the acid-base status of the internal milieu of tumors. , 1965, Journal of the National Cancer Institute.

[271]  M. Kongshaug.  Distribution of tetrapyrrole photosensitizers among human plasma proteins. , 1992, The International journal of biochemistry.

[272]  B. Allison,et al.  Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative. , 1994, British Journal of Cancer.

[273]  B. Tromberg,et al.  In vivo TUMOR OXYGEN TENSION MEASUREMENTS FOR THE EVALUATION OF THE EFFICIENCY OF PHOTODYNAMIC THERAPY , 1990, Photochemistry and photobiology.

[274]  Chin-Tin Chen,et al.  Use of Merocyanine 540 for Photodynamic Inactivation of Staphylococcus aureus Planktonic and Biofilm Cells , 2004, Applied and Environmental Microbiology.

[275]  P. Ripley.  The physics of diode lasers , 1996, Lasers in Medical Science.

[276]  R. Lauffer,et al.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.

[277]  P. Gullino,et al.  THE INTERSTITIAL FLUID OF SOLID TUMORS. , 1964, Cancer research.

[278]  J. Alexander,et al.  Comparison of translocation of different types of microorganisms from the intestinal tract of burned mice. , 2001, Shock.

[279]  C. Haie-meder,et al.  New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET. , 2008, Cancer treatment reviews.

[280]  J. Blais,et al.  Photodynamic efficiency of diethylene glycol-linked glycoconjugated porphyrins in human retinoblastoma cells. , 2006, Journal of medicinal chemistry.

[281]  K. Berg,et al.  Role of endosomes in gene transfection mediated by photochemical internalisation (PCI) , 2000, The journal of gene medicine.

[282]  B W Henderson,et al.  Interaction of photodynamic therapy and hyperthermia: tumor response and cell survival studies after treatment of mice in vivo. , 1985, Cancer research.